Integrated Approaches

Connecting Mechanistic Insight with Functional Outcomes

BRT integrates in vitro, in vivo, ex vivo, and bioanalytical capabilities to support customized preclinical research programs evaluating immune safety, function, and therapeutic efficacy.

Integrating In Vitro + In Vivo Approaches

BRT’s in vitro and in vivo capabilities can be combined within customized research programs to provide complementary insight into immune responses, safety, and therapeutic efficacy.

In Vitro Approaches

Mechanistic and cell-based assessments to evaluate immune function, sensitization, and biological responses.

In Vivo Approaches

Rodent-based models to evaluate immune function, host resistance, hypersensitivity, and therapeutic efficacy.

Integrated Ex Vivo Assessments

In vivo studies can be integrated with ex vivo assessments to further characterize immune function and treatment-related responses.

Bioanalytical and Cell-Based Assays Support

BRT’s bioanalytical capabilities can be integrated with in vitro and in vivo studies to support characterization of immune responses and study-related endpoints.

Immunogenicity Assessments
Cytokine & Chemokine Analysis
Complement Assessment
ELISA & ELISpot
Multiplex & MSD
Flow Cytometry
Cell-Based Assays
PK / TK

Customized Integrated Research

BRT works with clients to combine in vitro, in vivo, ex vivo, and bioanalytical capabilities based on specific research objectives, test articles, and study endpoints.

Let's Build an Integrated Research Approach

We work with clients to develop customized research programs that integrate in vitro, in vivo, ex vivo, and bioanalytical capabilities based on individual scientific objectives and study needs.